Back to search
FDAFDA · Food and drugs·Recall number D-0163-2020

Gatifloxacin Ophthalmic Solution 0.5%, For Use in the Eyes Only, Rx Only, Sterile, 2.5 mL bottle, Manufactured by Alcon Laboratories, Inc. Fort Worth, Texas 76134 for Sandoz Inc. Princeton, NJ 08540, Product of India, NDC 61314-672-25.

Published November 6, 2019 · Recall initiated: October 17, 2019

Summary

FDA records drug Class III recall D-0163-2020, published November 6, 2019 and initiated October 17, 2019. Recalling firm: Sandoz Inc; Status: Terminated; Reported quantity: 76,644 bottles; Lot: Lot #s: 289210F, Exp. 10/31/2019; 290632F, Exp. 10/31/2020. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Labeling: Incorrect or missing package insert.

What to do

Voluntary: Firm initiated · Letter

Get an email if GATIFLOXACIN has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
GATIFLOXACIN
Manufacturer
Sandoz Inc
Distributor
Nationwide in the U.S.
Lot
Lot #s: 289210F, Exp. 10/31/2019; 290632F, Exp. 10/31/2020
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Gatifloxacin Ophthalmic Solution 0.5%, For Use in the Eyes Only, Rx Only, Sterile, 2.5 mL bottle, Manufactured by Alcon Laboratories, Inc. Fort Worth, Texas 76134 for Sandoz Inc. Princeton, NJ 08540, Product of India, NDC 61314-672-25. recalled?

Yes. FDA published recall D-0163-2020 on November 6, 2019. Reported hazard: Labeling: Incorrect or missing package insert.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: GATIFLOXACIN.